LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Fresenius Medical Care AG & Co KGaA

Fermé

28.52 -0.35

Résumé

Variation du prix de l'action

24h

Actuel

Min

28.46

Max

28.57

Chiffres clés

By Trading Economics

Revenu

71M

190M

Ventes

-203M

4.9B

P/E

Moyenne du Secteur

24

51.198

BPA

0.42

Rendement du dividende

2.73

Marge bénéficiaire

3.884

Employés

112,035

EBITDA

460M

741M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+25.76% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

2.73%

2.40%

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

1.9B

17B

Ouverture précédente

28.87

Clôture précédente

28.52

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

Fresenius Medical Care AG & Co KGaA Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

30 mai 2025, 12:58 UTC

Market Talk

Weaker Dollar to Weigh on European Luxury, Healthcare, Aerospace Sectors -- Market Talk

6 mai 2025, 07:06 UTC

Market Talk
Résultats

Fresenius Medical Care's Results Are Solid But U.S. Dialysis Treatment Growth Disappoints -- Market Talk

6 mai 2025, 06:42 UTC

Market Talk
Résultats

Fresenius Medical Care's Results Should Lead to Positive Market Reaction -- Market Talk

21 mars 2025, 08:19 UTC

Market Talk

Fresenius Medical Care's Revenue Estimates Lowered by Jefferies on U.S. Volume Concerns -- Market Talk

25 févr. 2025, 10:27 UTC

Market Talk
Résultats

Fresenius Medical Care's U.S. Volume Growth Is Unlikely to Reassure Investors -- Market Talk

15 juil. 2024, 08:17 UTC

Market Talk

Fresenius Medical Care, DaVita Brace for Competition, Shift to Home Dialysis -- Market Talk

Comparaison

Variation de prix

Fresenius Medical Care AG & Co KGaA prévision

Objectif de Prix

By TipRanks

25.76% hausse

Prévisions sur 12 Mois

Moyen 36.03 USD  25.76%

Haut 49.202 USD

Bas 28.9 USD

Basé sur 4 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

4 ratings

2

Achat

1

Maintien

1

Vente

Score Technique

By Trading Central

25.57 / 28.18Support & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Weak Bullish Evidence

Long Terme

Weak Bullish Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Fresenius Medical Care AG & Co KGaA

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.